Onyx Pharmaceuticals, Inc. Stock price
Equities
US6833991093
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Aug. 27 | Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen | RE |
Aug. 26 | Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost | RE |
1st Jan change | Capi. | |
---|---|---|
+2.56% | 108B | |
+10.02% | 104B | |
+6.35% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |